Cardio Diagnostics Holdings, Inc. (CDIO)

US — Healthcare Sector
Peers: ZVSA  PALI  UNCY  IMMX  OCEA  HSCS  FOXO 

Automate Your Wheel Strategy on CDIO

With Tiblio's Option Bot, you can configure your own wheel strategy including CDIO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CDIO
  • Rev/Share 0.0118
  • Book/Share 6.7474
  • PB 0.6358
  • Debt/Equity 0.0532
  • CurrentRatio 19.4879
  • ROIC -0.4873

 

  • MktCap 7459066.0
  • FreeCF/Share -3.1977
  • PFCF -1.3834
  • PE -1.2355
  • Debt/Assets 0.0493
  • DivYield 0
  • ROE -0.8456

 

  • Rating B-
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 5
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
CDIO
Published: May 08, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.

Read More
image for news Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session
CDIO
Published: March 26, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.

Read More
image for news Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

About Cardio Diagnostics Holdings, Inc. (CDIO)

  • IPO Date 2022-01-14
  • Website https://cardiodiagnosticsinc.com
  • Industry Biotechnology
  • CEO Meeshanthini V. Dogan
  • Employees 13
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.